Abstract
Owing to the actual increase of mechanical circulatory support durations, total or partial replacement of ventricular assist devices (VADs) will most certainly have to be performed with increasing frequency. Herein we report the case of a patient in whom an INCOR (Berlin Heart AG, Berlin) implantable axial-flow pump was replaced without the use of cardiopulmonary bypass (CPB), underscoring some of the unique features provided by this system.
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Aspirin / therapeutic use
-
Clopidogrel
-
Equipment Design
-
Heart-Assist Devices
-
Humans
-
Infusion Pumps, Implantable*
-
International Normalized Ratio
-
Male
-
Middle Aged
-
Myocardial Ischemia / complications
-
Myocardial Ischemia / surgery*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Ticlopidine / analogs & derivatives
-
Ticlopidine / therapeutic use
-
Treatment Outcome
-
Ventricular Dysfunction, Left / drug therapy*
-
Ventricular Dysfunction, Left / etiology
-
Ventricular Dysfunction, Left / surgery
-
Warfarin / administration & dosage
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Platelet Aggregation Inhibitors
-
Warfarin
-
Clopidogrel
-
Ticlopidine
-
Aspirin